Pharmacy

Senate committee invites 7 pharma leaders to testify at drug price hearing

The Senate Finance Committee on Feb. 4 invited leaders from seven major drug companies to testify at a hearing about high prescription drug costs later this month, reports Reuters.

By: Mackenzie Bean

Tuesday, February 5th, 2019

Committee Chairman Sen. Chuck Grassley, R-Iowa, and ranking member Sen. Ron Wyden, D-Ore., invited the following companies to attend:

AbbVie
AstraZeneca
Bristol-Myers Squibb Co.
Johnson & Johnson
Merck & Co.
Pfizer
Sanofi

The Senate Finance Committee held an initial hearing on drug prices in January, during which Mr. Grassley denounced drug executives’ lack of attendance. The senators said some of these drug companies have been re-invited to the next hearing, although they did not say which.

More articles on pharmacy:
Despite controversies, J&J ranks among Fortune’s most-admired companies
Bristol-Myers swings to $1.2B profit in Q4
Bernie Sanders takes aim at drug’s $375K price tag

Next Up in Pharmacy

FDA approves twice-yearly injectable HIV drug

The FDA has approved Gilead Sciences’ lenacapavir, a twice-yearly injectable medication to prevent HIV, making it the first drug approved…

By: Alexandra Murphy
19 hours ago
Drug shortages cost hospitals $894M in labor, 150% more in 5 years

Hospital labor costs related to drug shortage management have significantly increased, from $359 million in 2019 to $894 million in…

By: Paige Twenter
Yesterday
FDA delays decision on hereditary disease drug

The FDA has delayed its decision to approve a new treatment for hereditary angioedema, citing a heavy workload and limited…

By: Alexandra Murphy
Yesterday

Comments are closed.

AI-agents in Action: Revolutionizing Navigation by Driving Personalized Care and Trust

Next Up in Pharmacy

FDA approves twice-yearly injectable HIV drug

Drug shortages cost hospitals $894M in labor, 150% more in 5 years

FDA delays decision on hereditary disease drug

Stay Informed with Becker’s Hospital Review Newsletter